Axsome settles Auvelity patent litigation with Teva
by Contributor since / Followers
1 month ago
JHVEPhoto
Axsome Therapeutics (NASDAQ:AXSM) stock rallied 15% in morning trading on news it has settled patent litigation with Teva (NYSE:TEVA) over its antidepressant drug Auvelity.
Axsome (NASDAQ:AXSM) had sued for patent infringement after Teva (NYSE:TEVA) filed an application
